Wockhardt hit by fresh UK ban
Wockhardt Hit By Fresh UK Ban. Britain's drug authorities have revoked their approval for one of Wockhardt's key plants -- a fresh regulatory rebuke...
MUMBAI: Britain's drug authorities have revoked their approval for one of Wockhardt's key plants -- a fresh regulatory rebuke that sent shares in the Indian drugmaker tumbling and underscoring the long road it faces in restoring its reputation.
The withdrawal of the good manufacturing practice certificate means the generic drugmaker's Chikalthana plant — one of its main revenue generators — will no longer be able to supply many products to Britain.
The admonition comes on top of a ban on drug shipments to the US and Britain from a separate Wockhardt factory after hygiene and other compliance deficiencies were found. India's pharmaceutical industry has come under the spotlight for a string of compliance lapses over the past three years, that have resulted in more scrutiny as well as a record fine for Wockhardt rival Ranbaxy Laboratories.
9 Dec 2019 12:12 PM GMT